| Pharmaceutical active ingredients: |
| Interferon Alfa-2b |
| Available forms, composition and doses of Intron: |
| N / A |
| Intron medical category: |
| Human:Antineoplastic agentsAntiviralsImmunological chemotherapyInterferons |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L03AB05 - Interferon Alfa-2b |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Schering-Plough |
| Related documents and information about Intron: |
| Intron A prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Introcin | Sulfamethoxazole; Trimethoprim | Andromaco Laboratorios |
| Introl | Cromolyn | Unidentified Pharmaceutical Company |
| Introlan | Preparation for Enteral Nutrition Lactose-free, Gluten-free | Hormel HealthLabs |
| Introlite | Preparation for Enteral Nutrition | Abbott; Ross Products |
| Intromene | Trichlormethiazide | Unidentified Pharmaceutical Company |
| Intron A | Interferon Alfa-2b | Schering-Plough; Agencia Lei Va Hong; Bayer Schering Pharma; Essex; Fulford Pharmaceuticals; Merck; Trading Pharma; Zuellig Pharma |
| Intron A / Rebetol | Interferon Alfa-2b; Ribavirin | Schering-Plough; Essex |
| Intron A Multi-Dose | Interferon Alfa-2b | Schering-Plough; Agencia Lei Va Hong; Bayer Schering Pharma; Essex; Merck; Trading Pharma; Zuellig Pharma |
| Intron A Peg | Peginterferon Alfa-2b rbe | Schering-Plough |
| Intron A Pen Multidosis | Interferon Alfa-2b | Schering-Plough |